Skip to main content
SpringerLink
Log in

Diagnosis and Treatment of Pediatric Psoriasis: Current and Future

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Psoriasis is a common yet complex inflammatory dermatosis that may be seen in infants, children, and adolescents. The clinical presentation and course may be quite variable, and while patients with mild disease are often easily managed, those with recalcitrant or more severe disease often present a therapeutic dilemma given the number of therapies available and the relative lack of data on the efficacy and safety of use of these therapies in children. This review presents the reader with an overview of the current understanding of the pathophysiology, diagnosis, and treatment of pediatric psoriasis, with an emphasis on the available data in the literature that pertains to the use in children of currently available topical and systemic therapies, including topical corticosteroids, vitamin D analogs, phototherapy, systemic immunosuppressive medications, and biologic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermtol. 1985;13(3):450–6.

    Article  CAS  Google Scholar 

  2. Fan X, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China. JEADV. 2007;21(6):762–5.

    PubMed  CAS  Google Scholar 

  3. Henseler T. The genetics of psoriasis. J Am Acad Dermatol. 1997;37(2 Pt 3):S1–11.

    Article  PubMed  CAS  Google Scholar 

  4. Farber EM, Nall ML. Epidemiology: natural history and genetics. In: Roienigk HH, Maibach HI, editors. Psoriasis. 3rd ed. New York: Marcel Dekker; 1998. p. 107–58.

    Google Scholar 

  5. Kumar B, Jain R, Sandhu K, et al. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol. 2004;43(9):654–8.

    Article  PubMed  Google Scholar 

  6. Kwon HH, Na SJ, Jo SJ, et al. Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic. J Dermatol. 2012;39(3):260–4.

    Article  PubMed  Google Scholar 

  7. Tollefson MM, Crowson CS, McEvoy MT, et al. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62(6):979–87.

    Article  PubMed  Google Scholar 

  8. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148(1):1–18.

    Article  PubMed  CAS  Google Scholar 

  9. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17(3):174–8.

    Article  PubMed  CAS  Google Scholar 

  10. Neville EA, Finn OA. Psoriasiform napkin dermatitis: a follow-up study. Br J Dermatol. 1975;92(3):279–85.

    Article  PubMed  CAS  Google Scholar 

  11. Farber EM, Mullen RH, Jacobs AH, et al. Infantile psoriasis: a follow-up study. Pediatr Dermatol. 1986;3(3):237–43.

    Article  PubMed  CAS  Google Scholar 

  12. Boje Rasmussen H, Hagdrup H, Schmidt H. Psoriasiform napkin dermatitis. Acta Derm Venereol. 1986;66(6):534–6.

    PubMed  CAS  Google Scholar 

  13. Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol. 2011;23(5):437–43.

    Article  PubMed  Google Scholar 

  14. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573.

    Article  PubMed  Google Scholar 

  15. Ramsey SE, Bolaria RK, Cabral DA, et al. Comparison of criteria for the classification of childhood arthritis. J Rheumatol. 2000;27(5):1283–6.

    PubMed  CAS  Google Scholar 

  16. Stoll ML, Nigrovic PA, Gotte AC, et al. Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis. Clin Exp Rheumatol. 2011;29(3):582–8.

    PubMed  CAS  Google Scholar 

  17. Augustin M, Glaeske G, Radtke MA, et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633–6.

    Article  PubMed  CAS  Google Scholar 

  18. Au SC, Goldminz AM, Loo DS, et al. Association between pediatric psoriasis and the metabolic syndrome. J Am Acad Dermatol. 2012;66(6):1012–3.

    Article  PubMed  Google Scholar 

  19. Koebnick C, Black MH, Smith N, et al. The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr. 2011;159(4):577–83.

    Article  PubMed  CAS  Google Scholar 

  20. Volf EM, Levine DE, Michelon MA, et al. Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts. J Drugs Dermatol. 2011;10(8):900–1.

    PubMed  Google Scholar 

  21. Zamberk P, Velazquez D, Campos M, et al. Paediatric psoriasis: narrowband UVB treatment. JEADV. 2010;24(4):415–9.

    PubMed  CAS  Google Scholar 

  22. Bilgic A, Bilgic O, Akis HK, et al. Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis. Pediatr Derm. 2010;27(6):614–7.

    Article  Google Scholar 

  23. Varni JW, Globe DR, Gandra SR, et al. Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases. Eur J Pediatr. 2012;171(3):485–92.

    Article  PubMed  Google Scholar 

  24. Michalak-Stoma A, Pietrzak A, Szepietowski JC, et al. Cytokine network in psoriasis revisited. Eur Cytokine Netw. 2011;22(4):160–8.

    PubMed  CAS  Google Scholar 

  25. Nair RP, Stuart PE, Nistor I, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006;78(5):827–51.

    Article  PubMed  CAS  Google Scholar 

  26. Mallon E, Bunce M, Savoie H, et al. HLA-C and guttate psoriasis. Br J Dermatol. 2000;143(6):1177–82.

    Article  PubMed  CAS  Google Scholar 

  27. Jordan CT, Cao L, Roberson ED, et al. PSORS2 is due to mutations in CARD14. Am J Hum Genet. 2012;90(5):784–95.

    Article  PubMed  CAS  Google Scholar 

  28. Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. New Engl J Med. 2011;365(7):620–8.

    Article  PubMed  CAS  Google Scholar 

  29. Rahman P, Elder JT. Genetics of psoriasis and psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012;39(2):431–3.

    Article  PubMed  CAS  Google Scholar 

  30. Chandran V. The genetics of psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol. 2013;14(2):149–56.

    Article  CAS  Google Scholar 

  31. Ozden MG, Tekin NS, Gurer MA, et al. Environmental risk factors in pediatric psoriasis: a multicenter case-control study. Pediatr Dermatol. 2011;28(3):306–12.

    Article  PubMed  Google Scholar 

  32. Rasmussen JE. The relationship between infection with group A beta hemolytic streptococci and the development of psoriasis. Pediatr Infect Dis J. 2000;19(2):153–4.

    PubMed  CAS  Google Scholar 

  33. Leung DY, Travers JB, Giorno R, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest. 1995;96(5):2106–12.

    Article  PubMed  CAS  Google Scholar 

  34. Honig PJ. Guttate psoriasis associated with perianal streptococcal disease. J Pediatr. 1988;113(6):1037–9.

    Article  PubMed  CAS  Google Scholar 

  35. Owen CM, Chalmers RJ, O’Sullivan T, et al. Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev. 2000;2:CD001976.

    PubMed  Google Scholar 

  36. Eberhard BA, Sundel RP, Newburger JW, et al. Psoriatic eruption in Kawasaki disease. J Pediatr. 2000;137(4):578–80.

    Article  PubMed  CAS  Google Scholar 

  37. Han MH, Jang KA, Sung KJ, et al. A case of guttate psoriasis following Kawasaki disease. Br J Dermatol. 2000;142(3):548–50.

    Article  PubMed  CAS  Google Scholar 

  38. Kishimoto S, Muneuchi J, Takahashi Y, et al. Psoriasiform skin lesion and supprative acrodermatitis associated with Kawasaki disease followed by the treatment with infliximab: a case report. Acta Paediatr. 2010;99(7):1102–4.

    Article  PubMed  CAS  Google Scholar 

  39. Liao YC, Lee JY. Psoriasis in a 3-month-old infant with Kawasaki disease. Dermatol Online J. 2009;15(11):10.

    PubMed  Google Scholar 

  40. Ergin S, Karaduman A, Demirkaya E, et al. Plaque psoriasis induced after Kawasaki disease. Turk J Pediatr. 2009;51(4):375–7.

    PubMed  Google Scholar 

  41. Yoon SY, Oh ST, Lee JY, et al. Plaque type psoriasiform eruption following Kawasaki disease. Pediatr Dermatol. 2007;24(3):336–7.

    Article  PubMed  Google Scholar 

  42. Yoon SY, Oh ST, Lee JY, et al. A plaque type psoriasiform eruption following Kawasaki disease. Pediatr Dermatol. 2007;24(1):96–8.

    Article  PubMed  Google Scholar 

  43. Mizuno Y, Suga Y, Muramatsu S, et al. Psoriasiform and palmoplanter pustular lesions induced after Kawasaki disease. Int J Dermatol. 2006;45(9):1080–2.

    Article  PubMed  Google Scholar 

  44. Menni S, Gualandri L, Boccardi D, et al. Association of psoriasis-like eruption and Kawasaki disease. J Dermatol. 2006;33(8):571–3.

    Article  PubMed  Google Scholar 

  45. Tsai HJ, Wu WM, Chang YC, et al. Annular pustules in Kawasaki disease: a further case indicating the association with psoriasis? Cutis. 2003;72(5):354–6.

    PubMed  Google Scholar 

  46. Zvulunov A, Greenberg D, Cagnano E, et al. Development of psoriatic lesions during acute and convalescent phases of Kawasaki disease. J Paediatr Child Health. 2003;39(3):229–31.

    Article  PubMed  CAS  Google Scholar 

  47. Garty B, Mosseri R, Finkelstein Y. Guttate psoriasis following Kawasaki disease. Pediatr Dermatol. 2001;18(6):507–8.

    Article  PubMed  CAS  Google Scholar 

  48. Rogers M. Childhood psoriasis. Curr Opin Pediatr. 2002;14(4):404–9.

    Article  PubMed  Google Scholar 

  49. Howard R, Tsuchiya A. Adult skin disease in the pediatric patient. Dermatol Clin. 1998;16(3):593–608.

    Article  PubMed  CAS  Google Scholar 

  50. Morris A, Rogers M, Fischer G, et al. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001;18(3):188–98.

    Article  PubMed  CAS  Google Scholar 

  51. Nanda A, Kaur S, Kaur I, et al. Childhood psoriasis: an epidemiologic survey of 112 patients. Pediatr Dermatol. 1990;7(1):19–21.

    Article  PubMed  CAS  Google Scholar 

  52. al-Fouzan AS, Nanda A. A survey of childhood psoriasis in Kuwait. Pediatr Dermatol. 1994;11(2):116–9.

    Article  PubMed  CAS  Google Scholar 

  53. Hutton KP, Orenberg EK, Jacobs AH. Childhood psoriasis. Cutis. 1987;39(1):26–7.

    PubMed  CAS  Google Scholar 

  54. Rasmussen JE. Psoriasis in children. Dermatol Clin. 1986;4(1):99–106.

    PubMed  CAS  Google Scholar 

  55. Nyfors A, Lemholt K. Psoriasis in children: a short review and a survey of 245 cases. Br J Dermatol. 1975;92(4):437–42.

    Article  PubMed  CAS  Google Scholar 

  56. Herbst RA, Hoch O, Kapp A, et al. Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy. J Am Acad Dermatol. 2000;42(5 Pt 2):885–7.

    Article  PubMed  CAS  Google Scholar 

  57. Nyfors A. Psoriasis in children: characteristics, prognosis and therapy: a review. Acta Derm Venereol Suppl (Stockh). 1981;95:47–53.

    CAS  Google Scholar 

  58. Tervaert WC, Esseveld H. A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica. 1970;140(5):282–90.

    Article  PubMed  CAS  Google Scholar 

  59. Whyte HJ, Baughman RD. Acute guttate psoriasis and streptococcal infection. Arch Dermatol. 1964;89:350–6.

    Article  PubMed  CAS  Google Scholar 

  60. Telfer NR, Chalmers RJ, Whale K, et al. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992;128(1):39–42.

    Article  PubMed  CAS  Google Scholar 

  61. Cordoro KM. Management of childhood psoriasis. Adv Dermatol. 2008;24:125–69.

    Article  PubMed  Google Scholar 

  62. Trueb RM. Therapies for childhood psoriasis. Curr Probl Dermatol. 2009;38:137–59.

    Article  PubMed  Google Scholar 

  63. Nanda A. Concomitance of psoriasis and atopic dermatitis. Dermatology. 1995;191(1):72.

    Article  PubMed  CAS  Google Scholar 

  64. Lever WF, Elder DE. Lever’s histopathology of the skin. 10th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2009.

    Google Scholar 

  65. Murphy M, Kerr P, Grant-Kels JM. The histopathologic spectrum of psoriasis. Clin Dermatol. 2007;25(6):524–8.

    Article  PubMed  Google Scholar 

  66. Vogel SA, Yentzer B, Davis SA, et al. Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol. 2012;148(1):66–71.

    Article  PubMed  CAS  Google Scholar 

  67. Lewkowicz D, Gottlieb AB. Pediatric psoriasis and psoriatic arthritis. Dermatol Ther. 2004;17(5):364–75.

    Article  PubMed  Google Scholar 

  68. Bhutani T, Kamangar F, Cordoro KM. Management of pediatric psoriasis. Pediatr Ann. 2012;41(1):e1–7.

    PubMed  Google Scholar 

  69. de Jager ME, de Jong EM, van de Kerkhof PC, et al. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010;62(6):1013–30.

    Article  PubMed  CAS  Google Scholar 

  70. Lara-Corrales I, Xi N, Pope E. Childhood psoriasis treatment: evidence published over the last 5 years. Rev Recent Clin Trials. 2011;6(1):36–43.

    Article  PubMed  CAS  Google Scholar 

  71. Gelmetti C. Therapeutic moisturizers as adjuvant therapy for psoriasis patients. Am J Clin Dermatol. 2009;10(Suppl. 1):7–12.

    Article  PubMed  Google Scholar 

  72. Herz G, Blum G, Yawalkar S. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis. J Am Acad Dermatol. 1991;25(6 Pt 2):1166–9.

    Article  PubMed  CAS  Google Scholar 

  73. Kimball AB, Gold MH, Zib B, et al. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol. 2008;59(3):448–54, 454.e1.

    Google Scholar 

  74. Ahn SJ, Oh SH, Chang SE, et al. A case of infantile psoriasis with pseudoainhum successfully treated with topical pimecrolimus and low-dose narrowband UVB phototherapy. JEADV. 2006;20(10):1332–4.

    PubMed  Google Scholar 

  75. Amichai B. Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream. JEADV. 2004;18(6):742–3.

    PubMed  CAS  Google Scholar 

  76. Mansouri P, Farshi S. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child. Dermatol Online J. 2006;12(2):7.

    PubMed  Google Scholar 

  77. Brune A, Miller DW, Lin P, et al. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol. 2007;24(1):76–80.

    Article  PubMed  Google Scholar 

  78. Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol. 2005;53(4):713–6.

    Article  PubMed  Google Scholar 

  79. Choi YJ, Hann SK, Chang SN, et al. Infantile psoriasis: successful treatment with topical calcipotriol. Pediatr Dermatol. 2000;17(3):242–4.

    Article  PubMed  CAS  Google Scholar 

  80. Darley CR, Cunliffe WJ, Green CM, et al. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol. 1996;135(3):390–3.

    Article  PubMed  CAS  Google Scholar 

  81. Oranje AP, Marcoux D, Svensson A, et al. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol. 1997;36(2 Pt 1):203–8.

    Article  PubMed  CAS  Google Scholar 

  82. Park SB, Suh DH, Youn JI. A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr Dermatol. 1999;16(4):321–5.

    Article  PubMed  CAS  Google Scholar 

  83. Patrizi A, Neri I, Rizzoli L, et al. Topical calcipotriol in childhood psoriasis. Acta Derm Venereol. 1999;79(6):477.

    Article  PubMed  CAS  Google Scholar 

  84. Perez A, Chen TC, Turner A, et al. Pilot study of topical calcitriol (1,25-dihydroxyvitamin D3) for treating psoriasis in children. Arch Dermatol. 1995;131(8):961–2.

    Article  PubMed  CAS  Google Scholar 

  85. Saggese G, Federico G, Battini R. Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children. Eur J Pediatr. 1993;152(5):389–92.

    Article  PubMed  CAS  Google Scholar 

  86. Travis LB, Silverberg NB. Psoriasis in infancy: therapy with calcipotriene ointment. Cutis. 2001;68(5):341–4.

    PubMed  CAS  Google Scholar 

  87. Comaish JS. Tar and related compounds in the therapy of psoriasis. Clin Exp Dermatol. 1981;6(6):639–45.

    Article  PubMed  CAS  Google Scholar 

  88. Lin AN, Moses K. Tar revisited. Int J Dermatol. 1985;24(4):216–8.

    Article  PubMed  CAS  Google Scholar 

  89. Borska L, Fiala Z, Krejsek J, et al. Immunologic changes in TNF-alpha, sE-selectin, sP-selectin, sICAM-1, and IL-8 in pediatric patients treated for psoriasis with the Goeckerman regimen. Pediatr Dermatol. 2007;24(6):607–12.

    Article  PubMed  Google Scholar 

  90. Kortuem KR, Davis MD, Witman PM, et al. Results of Goeckerman treatment for psoriasis in children: a 21-year retrospective review. Pediatr Dermatol. 2010;27(5):518–24.

    Article  PubMed  Google Scholar 

  91. Menter MA, Whiting DA, McWilliams J. Resistant childhood psoriasis: an analysis of patients seen in a day-care center. Pediatr Dermatol. 1984;2(1):8–12.

    Article  PubMed  CAS  Google Scholar 

  92. Borska L, Andrys C, Krejsek J, et al. Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckerman regimen. Pediatr Dermatol. 2009;26(1):23–7.

    Article  PubMed  Google Scholar 

  93. Diluvio L, Campione E, Paterno EJ, et al. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%. Pediatr Dermatol. 2007;24(3):332–3.

    Article  PubMed  Google Scholar 

  94. Zvulunov A, Anisfeld A, Metzker A. Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol. 1994;33(11):808–10.

    Article  PubMed  CAS  Google Scholar 

  95. Guerrier CJ, Porter DI. An open assessment of 0.1% dithranol in a 17% urea base (‘Psoradrate’ 0.1%) in the treatment of psoriasis of children. Curr Med Res Opin. 1983;8(6):446–50.

    Article  PubMed  CAS  Google Scholar 

  96. Pavlovsky M, Baum S, Shpiro D, et al. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis? JEADV. 2011;25(6):727–9.

    PubMed  CAS  Google Scholar 

  97. al-Fouzan AS, Nanda A. UVB phototherapy in childhood psoriasis. Pediatr Dermatol. 1995;12(1):66.

    Article  PubMed  CAS  Google Scholar 

  98. Pasic A, Ceovic R, Lipozencic J, et al. Phototherapy in pediatric patients. Pediatr Dermatol. 2003;20(1):71–7.

    Article  PubMed  Google Scholar 

  99. Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol. 1996;13(5):406–9.

    Article  PubMed  CAS  Google Scholar 

  100. Jain VK, Aggarwal K, Jain K, et al. Narrow-band UV-B phototherapy in childhood psoriasis. Int J Dermatol. 2007;46(3):320–2.

    Article  PubMed  Google Scholar 

  101. Pahlajani N, Katz BJ, Lozano AM, et al. Comparison of the efficacy and safety of the 308 nm excimer laser for the treatment of localized psoriasis in adults and in children: a pilot study. Pediatr Dermatol. 2005;22(2):161–5.

    Article  PubMed  Google Scholar 

  102. Gelfand JM, Wan J, Callis Duffin K, et al. Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol. 2012;148(4):487–94.

    Article  PubMed  CAS  Google Scholar 

  103. Patel RV, Clark LN, Lebwohl M, et al. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol. 2009;60(6):1001–17.

    Article  PubMed  Google Scholar 

  104. Beukelman T, Haynes K, Curtis JR, et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(4):1263–71.

    Article  PubMed  Google Scholar 

  105. Robinson A, Van Voorhees AS, Hsu S, et al. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67(2):279–88.

    Article  PubMed  CAS  Google Scholar 

  106. Kopp T, Karlhofer F, Szepfalusi Z, et al. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type. Br J Dermatol. 2004;151(4):912–6.

    Article  PubMed  CAS  Google Scholar 

  107. de Oliveira ST, Maragno L, Arnone M, et al. Generalized pustular psoriasis in childhood. Pediatr Dermatol. 2010;27(4):349–54.

    Article  PubMed  Google Scholar 

  108. Xiao T, Li B, He CD, et al. Juvenile generalized pustular psoriasis. J Dermatol. 2007;34(8):573–6.

    Article  PubMed  Google Scholar 

  109. Juanqin G, Zhiqiang C, Zijia H. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. Pediatr Dermatol. 1998;15(2):144–6.

    Article  PubMed  CAS  Google Scholar 

  110. Chao PH, Cheng YW, Chung MY. Generalized pustular psoriasis in a 6-week-old infant. Pediatr Dermatol. 2009;26(3):352–4.

    Article  PubMed  Google Scholar 

  111. Salleras M, Sanchez-Regana M, Umbert P. Congenital erythrodermic psoriasis: case report and literature review. Pediatr Dermatol. 1995;12(3):231–4.

    Article  PubMed  CAS  Google Scholar 

  112. Judge MR, McDonald A, Black MM. Pustular psoriasis in childhood. Clin Exp Dermatol. 1993;18(2):97–9.

    Article  PubMed  CAS  Google Scholar 

  113. Ergin S, Ersoy-Evans S, Sahin S, et al. Acitretin is a safe treatment option for infantile pustular psoriasis. J Dermatol Treat. 2008;19(6):341–3.

    Article  Google Scholar 

  114. Rosinska D, Wolska H, Jablonska S, et al. Etretinate in severe psoriasis of children. Pediatr Dermatol. 1988;5(4):266–72.

    Article  PubMed  CAS  Google Scholar 

  115. Karamfilov T, Wollina U. Juvenile generalized pustular psoriasis. Acta Derm Venereol. 1998;78(3):220.

    Article  PubMed  CAS  Google Scholar 

  116. Shelnitz LS, Esterly NB, Honig PJ. Etretinate therapy for generalized pustular psoriasis in children. Arch Dermatol. 1987;123(2):230–3.

    Article  PubMed  CAS  Google Scholar 

  117. Liao PB, Rubinson R, Howard R, et al. Annular pustular psoriasis: most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr Dermatol. 2002;19(1):19–25.

    Article  PubMed  Google Scholar 

  118. Al-Shobaili H, Al-Khenaizan S. Childhood generalized pustular psoriasis: successful treatment with isotretinoin. Pediatr Dermatol. 2007;24(5):563–4.

    Article  PubMed  Google Scholar 

  119. Kalb RE, Strober B, Weinstein G, et al. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009;60(5):824–37.

    Article  PubMed  Google Scholar 

  120. Kumar B, Dhar S, Handa S, et al. Methotrexate in childhood psoriasis. Pediatr Dermatol. 1994;11(3):271–3.

    Article  PubMed  CAS  Google Scholar 

  121. Dogra S, Handa S, Kanwar AJ. Methotrexate in severe childhood psoriasis. Pediatr Dermatol. 2004;21(3):283–4.

    Article  PubMed  Google Scholar 

  122. Dogra S, Kumaran MS, Handa S, et al. Methotrexate for generalized pustular psoriasis in a 2-year-old child. Pediatr Dermatol. 2005;22(1):85–6.

    Article  PubMed  Google Scholar 

  123. Kalla G, Goyal AM. Juvenile generalized pustular psoriasis. Pediatr Dermatol. 1996;13(1):45–6.

    Article  PubMed  CAS  Google Scholar 

  124. Kaur I, Dogra S, De D, et al. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol. 2008;25(2):184–8.

    Article  PubMed  Google Scholar 

  125. Garg T, Chander R, Mittal S. Familial juvenile generalized pustular psoriasis: response to methotrexate. Skinmed. 2011;9(3):190–1.

    PubMed  Google Scholar 

  126. Collin B, Vani A, Ogboli M, et al. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol. 2009;34(3):295–8.

    Article  PubMed  CAS  Google Scholar 

  127. Scott RB, Surana R. Erythrodermic psoriasis in childhood: a young Negro child treated with methotrexate. Am J Dis Child. 1968;116(2):218–21.

    PubMed  CAS  Google Scholar 

  128. Rosenbach M, Hsu S, Korman NJ, et al. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62(4):655–62.

    Article  PubMed  CAS  Google Scholar 

  129. Pereira TM, Vieira AP, Fernandes JC, et al. Cyclosporin A treatment in severe childhood psoriasis. JEADV. 2006;20(6):651–6.

    PubMed  CAS  Google Scholar 

  130. Perrett CM, Ilchyshyn A, Berth-Jones J. Cyclosporin in childhood psoriasis. J Dermatol Treat. 2003;14(2):113–8.

    CAS  Google Scholar 

  131. Kilic SS, Hacimustafaoglu M, Celebi S, et al. Low dose cyclosporin A treatment in generalized pustular psoriasis. Pediatr Dermatol. 2001;18(3):246–8.

    Article  PubMed  CAS  Google Scholar 

  132. Alli N, Gungor E, Karakayali G, et al. The use of cyclosporin in a child with generalized pustular psoriasis. Br J Dermatol. 1998;139(4):754–5.

    Article  PubMed  CAS  Google Scholar 

  133. Kim HS, Kim GM, Kim SY. Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin/narrowband ultraviolet B phototherapy. Pediatr Dermatol. 2006;23(3):306–8.

    Article  PubMed  Google Scholar 

  134. Nakamura S, Hashimoto Y, Igawa S, et al. Childhood generalized pustular psoriasis treated by preprandial ciclosporin administration: serum cytokine pattern during the course of the disease. Clin Exp Dermatol. 2009;34(8):e1023–4.

    Article  PubMed  CAS  Google Scholar 

  135. Mahe E, Bodemer C, Pruszkowski A, et al. Cyclosporine in childhood psoriasis. Arch Dermatol. 2001;137(11):1532–3.

    PubMed  CAS  Google Scholar 

  136. Marji JS, Marcus R, Moennich J, et al. Use of biologic agents in pediatric psoriasis. J Drugs Dermatol. 2010;9(8):975–86.

    PubMed  Google Scholar 

  137. Hashkes PJ, Uziel Y, Laxer RM. The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat Rev Rheumatol. 2010;6(10):561–71.

    Article  PubMed  CAS  Google Scholar 

  138. Dommasch ED, Abuabara K, Shin DB, et al. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2011;64(6):1035–50.

    Article  PubMed  CAS  Google Scholar 

  139. Pontikaki I, Shahi E, Frasin LA, et al. Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis. Clin Rev Allergy Immunol. 2012;42(2):131–4.

    Article  PubMed  CAS  Google Scholar 

  140. Gordon KB, Papp KA, Langley RG, et al. Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials. J Am Acad Dermatol. 2012;66(5):742–51.

    Article  PubMed  CAS  Google Scholar 

  141. Kimball AB, Gordon KB, Fakharzadeh S, et al. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years. Br J Dermatol. 2012;166(4):861–72.

    Article  PubMed  CAS  Google Scholar 

  142. Kimball AB, Gordon KB, Langley RG, et al. Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch Dermatol. 2008;144(2):200–7.

    Article  PubMed  CAS  Google Scholar 

  143. Gordon KB, Langley RG, Gottlieb AB, et al. A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis. J Invest Dermatol. 2012;132(2):304–14.

    Article  PubMed  CAS  Google Scholar 

  144. Strober BE, Crowley JJ, Yamauchi PS, et al. Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011;165(3):661–8.

    Article  PubMed  CAS  Google Scholar 

  145. Gottlieb AB, Leonardi C, Kerdel F, et al. Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011;165(3):652–60.

    Article  PubMed  CAS  Google Scholar 

  146. Kurzeja M, Rudnicka L, Olszewska M. New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab. Am J Clin Dermatol. 2011;12(2):113–25.

    Article  PubMed  Google Scholar 

  147. Hawrot AC, Metry DW, Theos AJ, et al. Etanercept for psoriasis in the pediatric population: experience in nine patients. Pediatr Dermatol. 2006;23(1):67–71.

    Article  PubMed  Google Scholar 

  148. Kress DW. Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis. J Am Acad Dermatol. 2006;54(3 Suppl. 2):S126–8.

    Article  PubMed  Google Scholar 

  149. Papoutsaki M, Costanzo A, Mazzotta A, et al. Etanercept for the treatment of severe childhood psoriasis. Br J Dermatol. 2006;154(1):181–3.

    Article  PubMed  CAS  Google Scholar 

  150. Safa G, Loppin M, Bousser AM, et al. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis. J Am Acad Dermatol. 2007;56(2 Suppl.):S19–20.

    Article  PubMed  Google Scholar 

  151. Fabrizi G, Guerriero C, Pagliarello C. Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept. Eur J Dermatol. 2007;17(3):245.

    PubMed  Google Scholar 

  152. Floristan U, Feltes R, Ramirez P, et al. Recalcitrant palmoplantar pustular psoriasis treated with etanercept. Pediatr Dermatol. 2011;28(3):349–50.

    Article  PubMed  Google Scholar 

  153. Pereira TM, Vieira AP, Fernandes JC, et al. Anti-TNF-alpha therapy in childhood pustular psoriasis. Dermatology. 2006;213(4):350–2.

    Article  PubMed  Google Scholar 

  154. Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. New Engl J Med. 2008;358(3):241–51.

    Article  PubMed  CAS  Google Scholar 

  155. Paller AS, Siegfried EC, Eichenfield LF, et al. Long-term etanercept in pediatric patients with plaque psoriasis. J Am Acad Dermatol. 2010;63(5):762–8.

    Article  PubMed  CAS  Google Scholar 

  156. Callen JP, Jackson JH. Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent. J Dermatol Treat. 2005;16(5–6):350–2.

    Article  CAS  Google Scholar 

  157. Alvarez AC, Rodriguez-Nevado I, De Argila D, et al. Recalcitrant pustular psoriasis successfully treated with adalimumab. Pediatr Dermatol. 2011;28(2):195–7.

    Article  PubMed  Google Scholar 

  158. Menter MA, Cush JM. Successful treatment of pediatric psoriasis with infliximab. Pediatr Dermatol. 2004;21(1):87–8.

    Article  PubMed  Google Scholar 

  159. Farnsworth NN, George SJ, Hsu S. Successful use of infliximab following a failed course of etanercept in a pediatric patient. Dermatol Online J. 2005;11(3):11.

    PubMed  Google Scholar 

  160. Rott S, Kuster RM, Mrowietz U. Successful treatment of severe psoriatic arthritis with infliximab in an 11-year-old child suffering from linear psoriasis along lines of Blaschko. Br J Dermatol. 2007;157(1):191–2.

    Article  PubMed  CAS  Google Scholar 

  161. Perman MJ, Lovell DJ, Denson LA, et al. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children. Pediatr Dermatol. 2012;29(4):454–9.

    Article  PubMed  Google Scholar 

  162. Hiremath G, Duffy L, Leibowitz I. Infliximab-induced psoriasis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;52(2):230–2.

    Article  PubMed  CAS  Google Scholar 

  163. Pourciau C, Shwayder T. Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab. Pediatr Dermatol. 2010;27(5):539–40.

    Article  PubMed  Google Scholar 

  164. Stuart P, Malick F, Nair RP, et al. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history. Arch Dermatol Res. 2002;294(5):207–13.

    PubMed  Google Scholar 

  165. Ferrandiz C, Pujol RM, Garcia-Patos V, et al. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46(6):867–73.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

No sources of funding were received to prepare this article. The author has no conflicts of interest that are directly relevant to the content of this article. The author would like to thank Dr. Kelly Cordoro for her critical review of therapeutic recommendations.

Author information

Authors and Affiliations

  1. Division of Dermatology, Cincinnati Children’s Hospital, 3333 Burnet Avenue, MLC 3004, Cincinnati, OH, 45243, USA

    Kara N. Shah

Authors
  1. Kara N. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kara N. Shah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, K.N. Diagnosis and Treatment of Pediatric Psoriasis: Current and Future. Am J Clin Dermatol 14, 195–213 (2013). https://doi.org/10.1007/s40257-013-0026-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-013-0026-8

Keywords

Search

Navigation